Inherited cardiomyopathy
Typical setting: Pathogenic variants affect sarcomere, cytoskeleton, nuclear envelope, or desmosomal proteins.
Defective force transmission or cellular stability produces progressive myocyte loss, fibrosis, and chamber dilatation.
Myocarditis
Typical setting: Viral injury or immune inflammation damages cardiomyocytes.
Incomplete recovery can leave cell loss and fibrosis that evolve into a chronic dilated phenotype.
Alcohol and cardiotoxins
Typical setting: Sustained alcohol exposure or selected cancer therapies injure mitochondria and contractile cells.
Cumulative toxicity reduces force and promotes oxidative injury; early removal may permit recovery.
Peripartum cardiomyopathy
Typical setting: Systolic dysfunction develops late in pregnancy or after birth without another explanation.
Vascular, hormonal, inflammatory, and susceptibility factors converge on myocardial dysfunction.
Persistent tachyarrhythmia
Typical setting: A rapid or highly irregular rhythm continues over weeks or months.
Short filling time, energy depletion, calcium dysregulation, and remodelling produce potentially reversible systolic failure.
Metabolic and systemic disease
Typical setting: Thyroid disease, iron overload, nutritional deficiency, autoimmune disease, or infection affects myocardium.
The mechanism varies from deposition and oxidative injury to hormonal or inflammatory disruption.